F.I.S.

FIS is one of the global CDMO leaders in Europe for small molecule APIs & Intermediates, driving innovation in drug development and production Founded in 1957 in Montecchio Maggiore (VI) and now controlled by the private equity fund Bain Capital, FIS has been partnering with the world's leading pharmaceutical companies for 70 years in the development and production of active pharmaceutical ingredients (APIs). With over 2,300 employees in Italy across three sites, offices in North America and Japan and an operational presence in China and India, we are a key international partner in Contract Development and Manufacturing (CDMO), specializing in Custom, Generic, and R&D services. Thanks to our production capacity and the expertise of over 270 R&D specialists, we can offer integrated solutions, from optimizing synthesis processes to scale-up and large-scale production for commercial quantities. Integrity, an unwavering focus on safety, product quality, and people’s well-being are at the core of our commitment to operating responsibly and sustainably.